Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Wuhan Hiteck Biological Pharma Co.,Ltd
—
Wuhan Hiteck Biological Pharma Co.,Ltd is led by CEO Wen Xian, employs 958 people, headquartered in Wuhan, CN, publicly traded since 2017.
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) stock trades at $22.93 with a market capitalization of $3.28B. The stock is valued at a negative price-to-earnings (P/E) ratio of -12.14, reflecting a net loss over the last twelve months, price-to-book of 1.62, price-to-sales of 6.67. Over the past 52 weeks the stock has ranged between $21.93 and $50.68, and currently trades 54.8% below its 52-week high.
On profitability, Wuhan Hiteck Biological Pharma Co.,Ltd generates a return on equity (ROE) of -12.35% (negative, reflecting a net loss), an operating margin of -91.81%, a net profit margin of -55.05%.
Official website: www.hiteck.com.cn
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) — frequently asked questions
What is Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) stock price today?
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) is currently trading at $22.93, down 4.58% today.
What is 300683.SZ P/E ratio?
Wuhan Hiteck Biological Pharma Co.,Ltd's P/E ratio is -12.14. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300683.SZ return on equity (ROE)?
Wuhan Hiteck Biological Pharma Co.,Ltd's return on equity (ROE) is -12.35%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Wuhan Hiteck Biological Pharma Co.,Ltd's market cap?
Wuhan Hiteck Biological Pharma Co.,Ltd has a market capitalization of $3.28B.
Does 300683.SZ pay a dividend?
Wuhan Hiteck Biological Pharma Co.,Ltd is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 300683.SZ carry?
Wuhan Hiteck Biological Pharma Co.,Ltd has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300683.SZ's profit margin?
Wuhan Hiteck Biological Pharma Co.,Ltd reports a net profit margin of -55.05% — the share of revenue left after every cost, including tax and interest.
What sector is 300683.SZ in?
Wuhan Hiteck Biological Pharma Co.,Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300683.SZ listed on?
Wuhan Hiteck Biological Pharma Co.,Ltd trades on SHZ under the ticker 300683.SZ.
What is 300683.SZ's 52-week range?
Over the last year Wuhan Hiteck Biological Pharma Co.,Ltd has traded between $21.93 and $50.68.
Related — Stocks
Popular Stocks
Screens 300683.SZ currently matches
On the figures above, Wuhan Hiteck Biological Pharma Co.,Ltd passes the filters for 8 of our ready-made screens, among them Low Debt Stocks, Debt Free Stocks Under $100, Debt Free Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.